Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Basal cell carcinoma
ADR ID BADD_A00426
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.08      Skin neoplasms malignant and unspecified
23.08.02      Skin neoplasms malignant and unspecified (excl melanoma)
23.08.02.001      Basal cell carcinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.03      Skin neoplasms malignant and unspecified
16.03.02      Skin neoplasms malignant and unspecified (excl melanoma)
16.03.02.001      Basal cell carcinoma
Description A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) [MeSH]
MedDRA Code 10004146
MeSH ID D002280
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Basal cell carcinoma | Basal cell epithelioma | Carcinoma basal cell | Fibroepithelioma of pinkus | Lip basal cell carcinoma | Metatypical basal cell carcinoma | Morpheaform basal cell carcinoma | Nodulo-ulcerative basal cell carcinoma | Pigmented basal cell carcinoma | Rodent ulcer | Sclerosing basal cell carcinoma | Superficial basal cell carcinoma | Morphoeaform basal cell carcinoma | Basal cell carcinoma of skin in situ | Basal cell carcinoma recurrent | Fibroepithelial basal cell carcinoma | Keratotic basal cell carcinoma | Micronodular basal cell carcinoma | Nodular basal cell carcinoma | Basalioma | Basal cell carcinoma of eyelid | Basal cell carcinoma face | Nodulocystic basal cell carcinoma | Basal cell carcinoma ear | Carcinoma, Basal Cell | Basal Cell Carcinoma | Basal Cell Carcinomas | Carcinomas, Basal Cell | Rodent Ulcer | Rodent Ulcers | Ulcers, Rodent | Ulcer, Rodent | Epithelioma, Basal Cell | Basal Cell Epithelioma | Basal Cell Epitheliomas | Epitheliomas, Basal Cell | Carcinoma, Basal Cell, Pigmented
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01966Ropinirole--
BADD_D01978Ruxolitinib0.001029%
BADD_D02018Sildenafil0.000161%
BADD_D02028Sirolimus0.000134%
BADD_D02029Sitagliptin0.000053%
BADD_D02031Sitaxentan--
BADD_D02066Spironolactone0.000037%
BADD_D02093Sulfasalazine0.000303%
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus0.004159%
BADD_D02106Tadalafil0.000195%
BADD_D02107Tafamidis0.000538%
BADD_D02150Temozolomide0.000112%
BADD_D02165Teriflunomide0.000964%
BADD_D02192Thalidomide0.000482%
BADD_D02236Tofacitinib0.004002%
BADD_D02257Trametinib0.000168%
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000132%
BADD_D02344Vemurafenib0.000895%
BADD_D02345Venetoclax0.000168%
BADD_D02365Vismodegib0.005809%
BADD_D02369Voriconazole0.040660%
BADD_D02375Water--
BADD_D02394Zolpidem0.000025%
BADD_D02407Upadacitinib0.001447%
BADD_D02412Octreotide--
BADD_D02464Fingolimod0.019024%
BADD_D02472Sonidegib0.000448%
BADD_D02487Baricitinib0.000241%
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages